To determine if seribantumab is inhibiting tumor growth by the intended mechanism, we collected tumors from the dose-ranging mouse xenograft study and measured both total and phosphorylated levels of ErbB3 by ELISA. This evidence concerns the gene ERBB3 and neoplasm.